Skip to main content
. 2020 Jun 3;12(6):609. doi: 10.3390/v12060609

Figure 2.

Figure 2

Cellular toxicity assessment of combinations of LRAs in uninfected cells. The effect of combinations of LRAs on cell viability in Jurkat cells (a) and human PBMCs (b) following 48 h treatment was measured with CellTiter-Blue® Cell Viability assay. Black columns represent untreated cells; red columns are cells treated with prostratin in combination with or without HDACis; green columns are cells treated with TPPB in combination with or without HDACis; blue columns are cells treated with indolactam in combination with or without HDACis; and white columns are cells treated with a single HDACi. Data are shown as mean ± S.D. of three independent experiments.